{"entity":{"type":"insider","cik":"0001731193","url":"/insider/0001731193","json_url":"/insider/0001731193.json","name":"AHMED NADIM","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2022-06-07","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"AHMED NADIM","source":"filing","n_filings":11,"first_seen":"2022-06-07","last_seen":"2026-02-25"}],"transactions":[{"id":5893883,"accession":"0001193125-26-072001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-072001","line_url":"/filing/0001193125-26-072001#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13515.0,"shares_display":"13,515","price_per_share":14.47,"price_display":"14.47","price_state":"stated","total_value":195562.05,"total_display":"195,562.05","total_whole":"195,562","shares_owned_after":390803.0,"shares_owned_after_display":"390,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":5836603,"accession":"0001193125-26-064254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-064254","line_url":"/filing/0001193125-26-064254#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16381.0,"shares_display":"16,381","price_per_share":13.62,"price_display":"13.62","price_state":"stated","total_value":223109.22,"total_display":"223,109.22","total_whole":"223,109","shares_owned_after":404318.0,"shares_owned_after_display":"404,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-23","scope":"insider"},{"id":4624786,"accession":"0001193125-25-335482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-335482","line_url":"/filing/0001193125-25-335482#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9922.0,"shares_display":"9,922","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":99319.22,"total_display":"99,319.22","total_whole":"99,319","shares_owned_after":420699.0,"shares_owned_after_display":"420,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-29","scope":"insider"},{"id":4027321,"accession":"0000950170-25-029199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-029199","line_url":"/filing/0000950170-25-029199#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12529.0,"shares_display":"12,529","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":106872.37,"total_display":"106,872.37","total_whole":"106,872","shares_owned_after":430621.0,"shares_owned_after_display":"430,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider"},{"id":2834319,"accession":"0000950170-24-140856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-140856","line_url":"/filing/0000950170-24-140856#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":11.87,"price_display":"11.87","price_state":"stated","total_value":99708.0,"total_display":"99,708.00","total_whole":"99,708","shares_owned_after":263150.0,"shares_owned_after_display":"263,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-27","scope":"insider"},{"id":8282549,"accession":"0000950170-23-073405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-073405","line_url":"/filing/0000950170-23-073405#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4272.0,"shares_display":"4,272","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":39473.28,"total_display":"39,473.28","total_whole":"39,473","shares_owned_after":111550.0,"shares_owned_after_display":"111,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-27","scope":"insider"},{"id":8518324,"accession":"0000950170-23-030805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-030805","line_url":"/filing/0000950170-23-030805#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":759.0,"shares_display":"759","price_per_share":11.4,"price_display":"11.40","price_state":"stated","total_value":8652.6,"total_display":"8,652.60","total_whole":"8,653","shares_owned_after":115822.0,"shares_owned_after_display":"115,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-28","filed_date":"2023-06-29","scope":"insider"},{"id":8599518,"accession":"0000950170-23-023939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-023939","line_url":"/filing/0000950170-23-023939#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":707.0,"shares_display":"707","price_per_share":9.15,"price_display":"9.15","price_state":"stated","total_value":6469.05,"total_display":"6,469.05","total_whole":"6,469","shares_owned_after":116581.0,"shares_owned_after_display":"116,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8620950,"accession":"0000950170-23-014838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-014838","line_url":"/filing/0000950170-23-014838#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":716.0,"shares_display":"716","price_per_share":10.59,"price_display":"10.59","price_state":"stated","total_value":7582.44,"total_display":"7,582.44","total_whole":"7,582","shares_owned_after":117288.0,"shares_owned_after_display":"117,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-26","scope":"insider"},{"id":8598309,"accession":"0000899243-23-009714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009714","line_url":"/filing/0000899243-23-009714#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":706.0,"shares_display":"706","price_per_share":10.51,"price_display":"10.51","price_state":"stated","total_value":7420.06,"total_display":"7,420.06","total_whole":"7,420","shares_owned_after":118004.0,"shares_owned_after_display":"118,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":6264072,"accession":"0000899243-22-021346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021346","line_url":"/filing/0000899243-22-021346#line-1","is_derivative":false,"issuer_cik":"0001731193","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001731193","owner_cik":"0001731193","owner_name":"AHMED NADIM","owner_display_name":"AHMED NADIM","owner_url":"/insider/0001731193","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8090.0,"shares_display":"8,090","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":100316.0,"total_display":"100,316.00","total_whole":"100,316","shares_owned_after":8090.0,"shares_owned_after_display":"8,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Therapeutics, Inc.","url":"/issuer/0001789972","role":"Director, Officer (President and CEO)","n_filings":11,"first_seen":"2022-06-07","last_seen":"2026-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001731193","retrieved_at":"2026-08-26T16:09:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}